Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Rational and scalable strategies to identify small “molecular glue” degraders

ABSTRACT: Rational and scalable strategies to identify small “molecular glue” degraders

PROVIDER: PRJNA596945 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10744478.fastq.gz	Fastqsanger.gz
	SRR10744479.fastq.gz	Fastqsanger.gz
	SRR10744480.fastq.gz	Fastqsanger.gz
	SRR10744481.fastq.gz	Fastqsanger.gz
	SRR10744482.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 18

Similar Datasets

Rational and scalable strategies to identify small “molecular glue” degraders

Project description:In our effort to characterize putatite novel molecular glues that we found in a phenotypic screen, we wanted to gain a more detailed understanding of the effects of these small-molecules at the trascriptome level.

2020-05-29 | GSE142405 | GEO

Design principles for cyclin K molecular glue degraders

Project description:Molecular glue degraders are an effective therapeutic modality, but their design principles are not well understood. Recently, several unexpectedly diverse compounds were reported to deplete cyclin K by linking CDK12-cyclin K to the DDB1-CUL4-RBX1 E3 ligase. To investigate how chemically dissimilar small molecules trigger cyclin K degradation, we evaluated 91 candidate degraders in structural, biophysical, and cellular studies and reveal all compounds acquire glue activity via simultaneous CDK12 binding and engagement of DDB1 interfacial residues, in particular Arg928. While we identify multiple published kinase inhibitors as cryptic degraders, we also show that these glues do not require pronounced inhibitory properties for activity and that the relative degree of CDK12 inhibition versus cyclin K degradation is tuneable. We further demonstrate cyclin K degraders have transcriptional signatures distinct from CDK12 inhibitors, thereby offering unique therapeutic opportunities. The systematic structure-activity relationship analysis presented herein provides a conceptual framework for rational molecular glue design.

2023-10-20 | PXD041836 | Pride

Rational discovery of molecular glue degraders via scalable chemical profiling.

Project description:Targeted protein degradation is a new therapeutic modality based on drugs that destabilize proteins by inducing their proximity to E3 ubiquitin ligases. Of particular interest are molecular glues that can degrade otherwise unligandable proteins by orchestrating direct interactions between target and ligase. However, their discovery has so far been serendipitous, thus hampering broad translational efforts. Here, we describe a scalable strategy toward glue degrader discovery that is based on chemical screening in hyponeddylated cells coupled to a multi-omics target deconvolution campaign. This approach led us to identify compounds that induce ubiquitination and degradation of cyclin K by prompting an interaction of CDK12-cyclin K with a CRL4B ligase complex. Notably, this interaction is independent of a dedicated substrate receptor, thus functionally segregating this mechanism from all described degraders. Collectively, our data outline a versatile and broadly applicable strategy to identify degraders with nonobvious mechanisms and thus empower future drug discovery efforts.

| S-EPMC7116640 | biostudies-literature

ProxiCapture reveals context-dependent CRBN interactome landscape of molecular glue degraders

Project description:Molecular glue degraders represent a rapidly expanding class of small molecules that reprogram E3 ubiquitin ligases to ubiquitinate and degrade disease-relevant proteins. Despite their therapeutic potential, the rational design of molecular glues remains challenging, underscoring the need for unbiased discovery strategies to identify new chemical targets. To address this challenge, we developed ProxiCapture, an affinity-based proteomics workflow that models the systemic behavior of molecular glues (MGs) by combining purified CRBN-ΔHBD protein with native cell or tissue lysates. ProxiCapture enables proteome-wide identification of degrader-dependent CRBN-protein interaction across diverse biological contexts.

2026-02-03 | PXD070656 | Pride

ProxiCapture reveals context-dependent CRBN interactome landscape of molecular glue degraders

2026-02-03 | PXD070637 | Pride

ProxiCapture reveals context-dependent CRBN interactome landscape of molecular glue degraders

2026-02-03 | PXD070567 | Pride

ProxiCapture Reveals Context-Dependent CRBN Interactome Landscape of Molecular Glue Degraders

2026-02-05 | PXD073192 | Pride

ProxiCapture reveals context-dependent CRBN interactome landscape of molecular glue degraders

2026-02-03 | PXD070621 | Pride

ProxiCapture reveals context-dependent CRBN interactome landscape of molecular glue degraders

2026-02-03 | PXD070945 | Pride

Project description:Rational discovery of Cyclin K molecular glue degraders via scalable chemical profiling